Glaxosmithkline Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Glaxosmithkline Phar	Ajanta Pharma	Ipca Laboratories
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	7.5 %	7.5 %	11.1 %
R&D as a % of Total Sales	0.07 %	5.0 %	3.12 %
Financials
5 yr Average ROE	40.73 %	21.63 %	13.55 %
5yr average Equity Multiplier	1.9	1.32	1.52
5yr Average Asset Turnover Ratio	0.94	0.84	0.76
5yr Avg Net Profit Margin	24.91 %	19.77 %	11.88 %
Price to Book	24.29	8.53	5.16
P/E	40.62	36.57	42.16
5yr Avg Cash Conversion Cycle	-107.65 Days	-102.34 Days	54.3 Days
Inventory Days	51.6 Days	55.16 Days	102.83 Days
Days Receivable	22.78 Days	49.8 Days	72.68 Days
Days Payable	144.46 Days	195.69 Days	111.38 Days
5yr Average Interest Coverage Ratio	479.64	108.5	50.79
5yr Avg ROCE	44.44 %	27.48 %	17.31 %
5yr Avg Operating Profit Margin	25.23 %	27.65 %	19.8 %
5 yr average Debt to Equity	0.0	0.0	0.17
5yr CAGR Net Profit	20.96 %	7.08 %	-8.34 %
5yr Average Return on Assets	21.84 %	16.51 %	9.41 %
Shareholdings
Promoter Holding	75.0 %	66.25 %	44.72 %
Share Pledged by Promoters	0.0	17.94 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.14 %	-1.57 %
Change in Mutual Fund Holding (3 Yrs)	0.77 %	1.45 %	1.3 %

Business

	Glaxosmithkline Phar	Ajanta Pharma	Ipca Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 76.0 Vaccines 24.0 Pharmaceutical products 0 API 0 Generics 0 Branded Generics 0	Product Wise Break-Up API 0 Branded Generics 0 Generics 0 Pharmaceutical 0 Pharmaceutical 100.0 Vaccines 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 16.53 Branded Generics 50.39 Formulations 33.08 Pharmaceutical 0 Pharmaceutical products 0 Vaccines 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 30.55 Anti-Infective 22.25 Vaccines 12.64 Pain Management 11.96 Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain 0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 3.27	Therapeutic Area Wise Break-Up - Domestic Cough Preparations 0 0 Anti-Infective 0 Urology 0 Neutraceuticals 0 Cardiovasculars & Anti-Diabetics 0 Hormones 0 Respiratory 0 Neuro Psychiatry 0 Vaccines 0 Dermatology 22.0 Pain Management 0 Anti-Bacterials 0 Anti-Malarials 0 Pain 10.0 Gastro-Intestinal (GI) Products 0 Vitamins / Minerals / Nutrients 0 Others 68.0	Therapeutic Area Wise Break-Up - Domestic Cough and colds 4.0 0 Anti-Infective 0 Urology 5.0 Neutraceuticals 1.0 Cardiac Science 17.0 Hormones 0 Respiratory 0 Central Nervous System (CNS) 3.0 Vaccines 0 Dermatology 6.0 Pain Management 0 Anti-bacterial 5.0 Anti Malarials 3.0 Pain 53.0 Gastro Intestinal 2.0 Vitamins / Minerals / Nutrients 0 Others 1.0
Location Wise Break-Up	Location Wise Break-Up India 98.65 Rest of the World 1.35 Asia 0 Africa 0 USA 0 Asia (Excluding India) 0 Australia 0 CIS 0 Europe 0	Location Wise Break-Up India 28.59 Rest of the World 0 Africa 16.28 Asia (Excluding India) 0 Australia 0 USA 35.74 CIS 0 Asia Pacific 19.39 Europe 0	Location Wise Break-Up India 44.73 Rest of the World 0 Africa 6.72 Asia Pacific 5.18 Australia 3.2 USA 21.58 CIS 2.91 Asia 0 Europe 15.68
Acute vs Chronic	Acute vs Chronic Acute 99.0 Chronic 1.0	-	-

Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE